## AXP: American Express Company - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.5% in mid entry zone (3.0-6.0%), top quartile (79th pct) cross-sectional ranking. Short-term MRS_5 (2.8%) confirms momentum alignment. Strong momentum (+5.6% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($366.17)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Amex Power Trio: Why These 3 Cards Deserve a Permanent Spot in My Wallet**
- Source: Upgraded Points | 20251216T143141 | Bullish | Relevance: 100%
- The author highlights three American Express cards — the Amex Platinum, Amex Gold, and Hilton Aspire — as essential for their wallet due to their unique benefits. The Amex Platinum excels in luxury travel and annual credits, the Amex Gold is a points-earning powerhouse for dining and groceries, and the Hilton Aspire provides top-tier hotel status and free night certificates. The article emphasizes maximizing the cards' extensive credits to offset high annual fees and accrue significant travel rewards.

**2. MASTERINVEST Kapitalanlage GmbH Makes New $4.46 Million Investment in American Express Company $AXP**
- Source: MarketBeat | 20251214T132548 | Neutral | Relevance: 100%
- MASTERINVEST Kapitalanlage GmbH has initiated a new $4.46 million investment in American Express Company (NYSE:AXP) by purchasing 13,979 shares. This comes as other institutional investors have also adjusted their holdings in American Express, which currently has a consensus "Hold" rating from analysts with an average target price of $332.65. Company insiders have recently sold shares, while American Express reported strong quarterly earnings, beating estimates.

**3. Morgan Stanley Adjusts PT on American Express to $370 From $362, Maintains Equalweight Rating**
- Source: marketscreener.com | 20251216T114959 | Somewhat-Bullish | Relevance: 100%
- Morgan Stanley has increased its price target for American Express (NYSE: AXP) to $370, up from the previous $362, while maintaining an Equalweight rating on the stock. This adjustment comes amidst other recent analyst activities, including some upward revisions and others maintaining their ratings. American Express also recently reported on card member loan write-off rates and consumer spending trends during the Thanksgiving week.

**4. American Express reports November card loan delinquency and write-off rates By Investing.com**
- Source: Investing.com South Africa | 20251215T180744 | Bullish | Relevance: 100%
- American Express released its November card loan delinquency and write-off statistics for U.S. Consumer and U.S. Small Business Card Member loans, showing stable delinquency rates for both segments. The company reported continued growth in total loans, robust financial health, and a consistent dividend payout. This information reflects American Express's ongoing financial management and strategic growth initiatives.

**5. Neville Rodie & Shaw Inc. Grows Holdings in American Express Company $AXP**
- Source: MarketBeat | 20251215T134655 | Somewhat-Bullish | Relevance: 100%
- Neville Rodie & Shaw Inc. increased its stake in American Express Company (NYSE:AXP) by 23.2% in the third quarter, now owning 51,810 shares valued at $17.21 million. This makes American Express its 21st largest holding, representing 1.2% of its investment portfolio. Other institutional investors also adjusted their positions, and Wall Street analysts have issued various ratings and price targets, with the company currently holding a consensus "Hold" rating and a target price of $332.65.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.28M) |
| Sells | 5 ($8.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Berkshire Hathaway, : 22.0% (0.0%)
- Vanguard Group Inc: 6.7% (-0.9%)
- JPMORGAN CHASE & CO: 6.4% (+133.0%)
- Blackrock Inc.: 6.2% (-1.3%)
- State Street Corpora: 4.2% (-1.2%)

### Key Risks

1. Insider selling cluster: $8.2M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +5.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.85 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%, margin 16%). Balance sheet: $5.6B free cash flow. Insider selling cluster ($8.2M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $266.2B |
| Beta | 1.15 |
| 52W Range | $220.43 - $387.49 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.85 |
| Forward P/E | 21.9 |
| Current P/E | 24.7 |
| YoY Growth | 13.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.0% to 4.5% (+5.6% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 79th percentile. MRS_5 at 2.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.90), confirming momentum. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.55% (CS: 80) | Strong |
| RSI_14 | 65.8 | Neutral |
| MACD Histogram | 1.90 | Bullish |
| vs SMA20 | 1.055x | Above |
| vs SMA50 | 1.077x | Above |
| vs SMA200 | 1.229x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $382.57
- **Stop Loss:** $366.17 (4.3% risk)
- **Target:** $407.17 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 73
- **Position Value:** $27,927.61
- **Portfolio %:** 27.93%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-23 (Est: $3.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.00 | $4.14 | +3.6% |
| 2025Q2 | $3.88 | $4.08 | +5.1% |
| 2025Q1 | $3.47 | $3.64 | +4.8% |
| 2024Q4 | $3.03 | $3.04 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*